CUHK_CCT00004
2005-09-06
Retrospective
Department of Obstetrics and Gynaecology
Nil
Nil
Chan Shing Chee, Symphorosa
Tel Tel 2632 2583
Chan Shing Chee, Symphorosa
Tel Tel 2632 2583
Randomized Control Trial of Levo-norgestrel Intrauterine System in Women Receiving Tamoxifen for Carcinoma of Breast
Yes
2001-03-20
Carcinoma of Breast on Tamoxifen
Device
Levo-norgestrel Intrauterine System (LNG-IUS, that is mirena)
5 years
Surveillance (with transvaginal ultrasound scan and outpatient hysteroscopy) for control group against Surveillance (TVS and outpatient hysteroscopy) and intervention with mirena insertion for the intervention group
Inclusion Criteria: 1. Patients with breast cancer using tamoxifen as an adjuvant therapy 2. Patients willing to give written consent to participate the study
Exclusion Criteria: 1. Patients with previous history of endometrial hyperplasia or endometrial carcinoma 2. Patients who are contraindicated to the use of LNG-IUS 3. Patients who have no intact uterus 4. Patients refuse to participate the study
Randomized
Placebo
Open label
Parallel
2001-04-01
120
Complete
Endometrial pathology by hysteroscopy in both groups
Histology of endometrial pathology in both groups
2009-11-25
Yes
|
|
|
|
|
---|---|---|---|---|
No documents yet. |